Affect Therapeutics, Inc. — Form D
Affect Therapeutics, Inc. of McLean, VA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-12. The offering totals $18.1M, of which $18.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-07-12
- Form: D
- Accession: 0001883067-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $18.1M
- Amount sold: $18.1M
- Investors: 9
- Date of first sale: 2022-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-486606
Issuer
- Name: Affect Therapeutics, Inc.
- CIK: 0001883067
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1640 Boro Place, McLean, VA, 22102
- Phone: 9295522849
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jeff DeFlavio | Director | New York, NY |
| Kristin Muhlner | Director | Alexandria, VA |
| Stuart Peterson | Director | San Francisco, CA |
| Jeff Rinehart | Director | PORTLAND, OR |
| Kevin Ryan | Director | Rumson, NJ |
| Kristin Muhlner | Executive Officer | Alexandria, VA |
Other filings by this issuer (1)
More